Dr. Orly Noivirt-Brik
Co-Founder & Co-CEO
Former Head of Bioinformatics and a member of the Leadership Team of Monsanto-Israel. Prior to that, Dr. Noivirt-Brik established the Bioinformatics department at Rosetta Green and led its R&D activity. Dr. Noivirt-Brik holds a PhD and M.SC. in Computational Biology from the Weizmann Institute of Science, and a B.Sc. in Chemistry and Biology (Summa Cum Laude) from Tel Aviv University.
Dr. Efrat Lidor Nili
Co-Founder & Co-CEO
Former Senior Scientist and a member of the Innovation Team of Monsanto-Israel. Prior to this Dr. Lidor Nili was a Senior Bioinformatician at Rosetta Green. Dr. Lidor Nili holds an interdisciplinary PhD from the Weizmann Institute of Science in which she combined molecular biology techniques with computational tools, a M.Sc. in Life Science from the Weizmann Institute of Science and a B.Sc. in Chemistry and Biology (Summa Cum Laude) from Tel-Aviv University.
Zeev has more than 20 years of experience in healthcare corporate development and leadership, strategic planning and corporate finance. Until 2017, Zeev served as CEO of Intec Pharma (NASDAQ, TASE: NTEC), a late clinical-stage biopharmaceutical company, including leading a NASDAQ IPO in August 2015, raising $34 million. Formerly, Zeev served as Intec's Executive Vice President Commercial Operations, including executing multiple collaboration agreements with global leading pharmaceutical companies. Prior to that, Zeev served as Head of Life Sciences Strategic Consulting with PWC Israel and Head of Life Sciences Strategic Consulting with Andersen Israel, leading numerous business development, corporate development, strategic planning and corporate finance consulting projects with various life sciences companies. Zeev is a Certified Public Accountant and has a BSc in Biology, a B.A. in accounting and has completed MSc studies in neuro-biochemistry, each from Tel Aviv University.